Literature DB >> 14625547

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

Susan M Kaech1, Joyce T Tan, E John Wherry, Bogumila T Konieczny, Charles D Surh, Rafi Ahmed.   

Abstract

A major unanswered question is what distinguishes the majority of activated CD8 T cells that die after an acute viral infection from the small fraction (5-10%) that survive to become long-lived memory cells. In this study we show that increased expression of the interleukin 7 receptor alpha-chain (IL-7Ralpha) identifies the effector CD8 T cells that will differentiate into memory cells. IL-7R(hi) effector cells contained increased amounts of antiapoptotic molecules, and adoptive transfer of IL-7R(hi) and IL-7R(lo) effector cells showed that IL-7R(hi) cells preferentially gave rise to memory cells that could persist and confer protective immunity. Thus, selective expression of IL-7R identifies memory cell precursors, and this marker may be useful in predicting the number of memory T cells generated after infection or immunization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625547     DOI: 10.1038/ni1009

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  831 in total

1.  Temporal expression of microRNA cluster miR-17-92 regulates effector and memory CD8+ T-cell differentiation.

Authors:  Tuoqi Wu; Andreas Wieland; Koichi Araki; Carl W Davis; Lilin Ye; J Scott Hale; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

2.  Differential localization of effector and memory CD8 T cell subsets in lymphoid organs during acute viral infection.

Authors:  Yong Woo Jung; Rachel L Rutishauser; Nikhil S Joshi; Ann M Haberman; Susan M Kaech
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

3.  Increased vitamin D is associated with decline of naïve, but accumulation of effector, CD8 T cells during early aging.

Authors:  Yong Gil Hwang; Hui-Chen Hsu; Fei-Chu Lim; Qi Wu; PingAr Yang; Gordon Fisher; Gary R Hunter; John D Mountz
Journal:  Adv Aging Res       Date:  2013-05

Review 4.  Molecular regulation of effector and memory T cell differentiation.

Authors:  John T Chang; E John Wherry; Ananda W Goldrath
Journal:  Nat Immunol       Date:  2014-12       Impact factor: 25.606

5.  Perforin plays an unexpected role in regulating T-cell contraction during prolonged Listeria monocytogenes infection.

Authors:  Nathan W Schmidt; Aaruni Khanolkar; Lisa Hancox; Jonathan W Heusel; John T Harty
Journal:  Eur J Immunol       Date:  2012-01-18       Impact factor: 5.532

Review 6.  Interlinking interleukin-7.

Authors:  Christina Kittipatarin; Annette R Khaled
Journal:  Cytokine       Date:  2007-09-04       Impact factor: 3.861

7.  Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure.

Authors:  Alexandre Harari; Felicitas Bellutti Enders; Cristina Cellerai; Pierre-Alexandre Bart; Giuseppe Pantaleo
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

8.  HVEM Imprints Memory Potential on Effector CD8 T Cells Required for Protective Mucosal Immunity.

Authors:  Pritesh Desai; Georges Abboud; Jessica Stanfield; Paul G Thomas; Jianxun Song; Carl F Ware; Michael Croft; Shahram Salek-Ardakani
Journal:  J Immunol       Date:  2017-09-01       Impact factor: 5.422

9.  The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

Authors:  Eui-Cheol Shin; Su-Hyung Park; Michelina Nascimbeni; Marian Major; Laura Caggiari; Valli de Re; Stephen M Feinstone; Charles M Rice; Barbara Rehermann
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

10.  Programming for CD8 T cell memory development requires IL-12 or type I IFN.

Authors:  Zhengguo Xiao; Kerry A Casey; Stephen C Jameson; Julie M Curtsinger; Matthew F Mescher
Journal:  J Immunol       Date:  2009-03-01       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.